Key terms
About ARAY
Accuray, Inc. is a radiation oncology company, which engages in the development, manufacture, and sale of treatment solutions that include CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Madison, WI.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ARAY news
Mar 06
11:25am ET
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 200%, Say Analysts
Feb 13
5:32am ET
Accuray’s Growth Prospects Bolstered by Strategic Market Expansion and Innovation, Recommends Buy
Feb 01
8:45am ET
Accuray (ARAY) Gets a Buy from Lake Street
Feb 01
6:47am ET
Accuray Buy Rating Affirmed on Strong Growth and Solid Financials Despite Headwinds
Jan 31
4:11pm ET
Accuray backs FY24 revenue view $460M-$470M, consensus $463.03M
Jan 31
4:10pm ET
Accuray sees Q3 revenue $112M-$118M, consensus $124.38M
Jan 31
4:09pm ET
Accuray reports Q2 EPS (10c), consensus (5c)
Jan 25
7:46am ET
Accuray Cybeknife system selected by Radiosurgery Center in Seattle
Jan 07
5:28am ET
BTIG Keeps Their Buy Rating on Accuray (ARAY)
Jan 02
9:10am ET
BTIG Keeps Their Buy Rating on Accuray (ARAY)
Dec 31
5:07am ET
Accuray (ARAY) Receives a Buy from BTIG
No recent press releases are available for ARAY
ARAY Financials
Key terms
Ad Feedback
ARAY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ARAY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range